parkinson, Parkinson's research notebook

Six readers

reader	found	score
genetics Open Targets	no genetic evidence; overall 0.00 from other evidence	0.00
cell type Human Protein Atlas	cell type enhanced in oligodendrocytes (865 nCPM)	1.00
chemistry Open Targets	a small-molecule pocket	0.60
trials ClinicalTrials.gov	no Parkinson's trials on record: an open field	1.00
literature PubMed	3 Parkinson's papers of 152	0.82
pathways Reactome	1 pathway; mostly other	0.30

No case: the score is under the bar. Receipt 12646

receipt 12654: AK5 in dopamine neurons, braak

power: full sample +0.11 (p 0.658, n 18), 95% CI -0.37 to +0.55. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: +0.11 (p 0.677, n 18). does not hold up.
composition: dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.11 (p 0.664, n 18). could be the mix.
skeptic: leave-one-out range -0.01 to +0.25, sign flips 1; without severely affected donors +0.11 (p 0.658, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for AK5 in dopamine neurons.

case closed: nothing better to follow up.

receipt 12653: AK5 in oligodendrocytes, braak

power: full sample +0.09 (p 0.709, n 18), 95% CI -0.39 to +0.54. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: +0.08 (p 0.754, n 18). does not hold up.
composition: oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.06 (p 0.800, n 18). could be the mix.
skeptic: leave-one-out range -0.02 to +0.23, sign flips 2; without severely affected donors +0.09 (p 0.709, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for AK5 in oligodendrocytes.

case closed: nothing better to follow up.

loading the receipts